MEIHUA INTL MEDICAL- CLASS A (MHUA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MHUA • KYG5966G1082

7.61 USD
-6.41 (-45.72%)
At close: Dec 8, 2025
6.11 USD
-1.5 (-19.71%)
After Hours: 12/8/2025, 8:26:08 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MHUA. MHUA was compared to 186 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year MHUA was profitable.
  • MHUA had a positive operating cash flow in the past year.
  • In the past 5 years MHUA has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • MHUA's Return On Assets of 7.34% is amongst the best of the industry. MHUA outperforms 88.24% of its industry peers.
  • MHUA has a Return On Equity of 8.48%. This is amongst the best in the industry. MHUA outperforms 81.82% of its industry peers.
  • With an excellent Return On Invested Capital value of 7.79%, MHUA belongs to the best of the industry, outperforming 83.96% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for MHUA is below the industry average of 8.80%.
  • The last Return On Invested Capital (7.79%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROIC 7.79%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.37%, MHUA belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MHUA has declined.
  • MHUA has a Operating Margin of 13.01%. This is amongst the best in the industry. MHUA outperforms 80.75% of its industry peers.
  • MHUA's Operating Margin has declined in the last couple of years.
  • MHUA has a worse Gross Margin (34.04%) than 74.87% of its industry peers.
  • MHUA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
  • MHUA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MHUA has been increased compared to 5 years ago.
  • MHUA has about the same debt/assets ratio as last year.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • MHUA has an Altman-Z score of 2.79. This is not the best score and indicates that MHUA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of MHUA (2.79) is better than 69.52% of its industry peers.
  • MHUA has a debt to FCF ratio of 3.19. This is a good value and a sign of high solvency as MHUA would need 3.19 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.19, MHUA belongs to the best of the industry, outperforming 82.89% of the companies in the same industry.
  • A Debt/Equity ratio of 0.07 indicates that MHUA is not too dependend on debt financing.
  • MHUA has a Debt to Equity ratio of 0.07. This is in the better half of the industry: MHUA outperforms 66.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Altman-Z 2.79
ROIC/WACC1.68
WACC4.63%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • MHUA has a Current Ratio of 5.71. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
  • MHUA has a Current ratio of 5.71. This is amongst the best in the industry. MHUA outperforms 81.28% of its industry peers.
  • A Quick Ratio of 5.66 indicates that MHUA has no problem at all paying its short term obligations.
  • MHUA has a Quick ratio of 5.66. This is amongst the best in the industry. MHUA outperforms 83.96% of its industry peers.
Industry RankSector Rank
Current Ratio 5.71
Quick Ratio 5.66
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

  • MHUA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.59%.
  • The earnings per share for MHUA have been decreasing by -13.75% on average. This is quite bad
  • The Revenue has decreased by -5.30% in the past year.
  • MHUA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.01% yearly.
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.53 indicates a correct valuation of MHUA.
  • Based on the Price/Earnings ratio, MHUA is valued cheaply inside the industry as 87.17% of the companies are valued more expensively.
  • MHUA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
Industry RankSector Rank
PE 15.53
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than MHUA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.19
EV/EBITDA -0.62
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The decent profitability rating of MHUA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield 0%

MEIHUA INTL MEDICAL- CLASS A

NASDAQ:MHUA (12/8/2025, 8:26:08 PM)

After market: 6.11 -1.5 (-19.71%)

7.61

-6.41 (-45.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29
Earnings (Next)N/A
Inst Owners0.23%
Inst Owner Change-1.85%
Ins Owners28.5%
Ins Owner ChangeN/A
Market Cap4.26M
Revenue(TTM)134.89M
Net Income(TTM)13.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.53
Fwd PE N/A
P/S 0.03
P/FCF 1.19
P/OCF 1.15
P/B 0.03
P/tB 0.03
EV/EBITDA -0.62
EPS(TTM)0.49
EY6.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.4
FCFY84.13%
OCF(TTM)6.64
OCFY87.26%
SpS240.88
BVpS294.54
TBVpS293.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number56.99
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROCE 10.64%
ROIC 7.79%
ROICexc 8.54%
ROICexgc 8.57%
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
FCFM 2.66%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexgc growth 3Y-27.75%
ROICexgc growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Debt/EBITDA 0.63
Cap/Depr 24.05%
Cap/Sales 0.1%
Interest Coverage 69.48
Cash Conversion 20.54%
Profit Quality 25.63%
Current Ratio 5.71
Quick Ratio 5.66
Altman-Z 2.79
F-Score5
WACC4.63%
ROIC/WACC1.68
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.66%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%

MEIHUA INTL MEDICAL- CLASS A / MHUA FAQ

Can you provide the ChartMill fundamental rating for MEIHUA INTL MEDICAL- CLASS A?

ChartMill assigns a fundamental rating of 5 / 10 to MHUA.


What is the valuation status of MEIHUA INTL MEDICAL- CLASS A (MHUA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MEIHUA INTL MEDICAL- CLASS A (MHUA). This can be considered as Fairly Valued.


What is the profitability of MHUA stock?

MEIHUA INTL MEDICAL- CLASS A (MHUA) has a profitability rating of 6 / 10.


What is the financial health of MEIHUA INTL MEDICAL- CLASS A (MHUA) stock?

The financial health rating of MEIHUA INTL MEDICAL- CLASS A (MHUA) is 7 / 10.